Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies

Cellular therapies with tolerogenic antigen-presenting cells (tolAPC) show great promise for the treatment of autoimmune diseases and for the prevention of destructive immune responses after transplantation. The methodologies for generating tolAPC vary greatly between different laboratories, making...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:PeerJ
Autores principales: Lord, Phillip, Spiering, Rachel, Aguillon, Juan C., Anderson, Amy E., Appel, Silke, Benitez-Ribas, Daniel, ten Brinke, Anja, Broere, Femke, Cools, Nathalie, Cuturi, Maria Cristina, Diboll, Julie, Geissler, Edward K., Giannoukakis, Nick, Gregori, Silvia, van Ham, S. Marieke, Lattimer, Staci, Marshall, Lindsay, Harry, Rachel A., Hutchinson, James A., Isaacs, John D., Joosten, Irma, van Kooten, Cees, Lopez Diaz de Cerio, Ascension, Nikolic, Tatjana, Oral, Haluk Barbaros, Sofronic-Milosavljevic, Ljiljana, Ritter, Thomas, Riquelme, Paloma, Thomson, Angus W., Trucco, Massimo, Vives-Pi, Marta, Martinez-Caceres, Eva M., Hilkens, Catharien M.U.
Formato: Artigo
Lenguaje:Inglês
Publicado: PeerJ Inc. 2016
Materias:
Clinical Trials
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5012269/
https://ncbi.nlm.nih.gov/pubmed/27635311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.2300
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares